Oxygen Delivery Index™

represents a function assessment of the microcirculatory system to diagnose circulatory failure on an individual patient basis

mLab™

enables capturing of microvascular data bedside using optical instruments for further assessment of microcirculatory function

cLab™

enables advanced analysis of microvascular hemodynamics and oxygen delivery
for assessment of microcirculatory function

About us

ODI Medical is developing technology for bedside measurement and quantification of circulatory failure based on assessment of microcirculation. Our concept, the Oxygen Delivery Index™, may be used for a wide range of clinical applications such as monitoring patients on mechanical heart and lung machines, evaluation of toxicity of chemotherapy, early detection of evolving sepsis, monitoring of chronic wounds, and mass screening of conditions such as Ebola, bird flu or endemic meningitis. ODI Medical is commercializing its concepts on the foundation of 30 years research from its founder, Professor Knut Kvernebo, from The Oslo University Hospital (OUS), Oslo, Norway.   

Latest News

Oslo 2016-10-15 From today ODI Medical has office space in The Medical Growth House located at...
Oslo 2016-01-01 ODI Medical has been granted 7.4 mill NOK over 2 years from The Research Council...
Oslo 2015-06-01 ODI Medical Founder Professor Knut Kvernebo at Oslo University Hospital has...

Management Team

Knut Kvernebo, Founder and CMO

Professor of Thoracic Surgery Knut Kvernebo (MD, PhD) founded ODI Medical based on 30 years of microvascular research.

Svein-Erik Måsøy, CEO

Svein-Erik Måsøy (MSc, PhD) has 17 years of experience from industry, innovation, and academic research within medical technology.

Jochen Rau, CTO

Jochen Rau (MSc, PhD) has a PhD in medical technology and has solid experience in development of medical technology.